Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2005
10/11/2005CA2341949C Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses
10/06/2005WO2005092904A1 Novel compounds for modulating cell proliferation
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092887A1 Compounds for the treatment of diseases
10/06/2005WO2005092860A1 Compounds for the treatment of diseases
10/06/2005WO2005092859A1 Ionic liquids of heterocyclic amines
10/06/2005WO2005092847A1 Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound
10/06/2005WO2005092845A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005WO2005092841A1 Compounds having beta-agonist activity
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005092833A1 Process for producing 1,2-ethanediamine derivative
10/06/2005WO2005055928A3 Zn2+ -chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
10/06/2005WO2005046599A3 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
10/06/2005WO2004072031A8 Phenylacetamides and their use as glucokinase modulators
10/06/2005US20050222443 Conversion of Group 4 metal amides to the corresponding metal alkyl complex of Lewis base ligand with a neutral source of a Lewis base ligand and a Lewis acid; catalysts in the polymerization of olefins to high molecular weight polymers
10/06/2005US20050222426 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
10/06/2005US20050222421 Process for preparing nicotinic acid and catalyst used in the method
10/06/2005US20050222420 Chain oligolactic acid thioester
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050222217 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags
10/06/2005US20050222213 Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
10/06/2005US20050222207 Phosphodiesterase 4 inhibitors, including N-substituted diarylamine analogs
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222151 Non-Imidazole heterocyclic compounds
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005US20050222140 Improved DP-IV inhibitors increase the steady state concentrations of GLP-1 and GIP, resulting in improved glucose tolerance
10/06/2005US20050221989 O-cyclopropyl-carboxanilides and their use as fungicides
10/06/2005US20050218532 higher reactivity with an electrophile; lithium chloride complexes; using organometallic R1(MgX).LiY, a fast exchange reaction occurs leading to Grignard reagents in high yields under mild conditions; ether solvent; phenyl-(4-cyanophenyl)methanol from benzaldehyde, 4-bromobenzonitrile and i-PrMgCl.LiCl
10/06/2005CA2560584A1 Novel compounds for modulating cell proliferation
10/06/2005CA2560368A1 Compounds for the treatment of diseases
10/06/2005CA2560243A1 Pharmaceutical dosage forms and compositions of 5-ht1a receptor antagonists
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005CA2557794A1 Opioid receptor antagonists
10/05/2005EP1582523A1 Method of preparing organomagnesium compounds
10/05/2005EP1582521A1 Fused furan compound
10/05/2005EP1582516A1 Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same
10/05/2005EP1581516A2 3-heterocyclic benzylamide derivatives as potassium channel openers
10/05/2005EP1581514A2 Chemical compounds
10/05/2005EP1581511A1 Ccr8 inhibitors
10/05/2005EP1581510A2 1-aryl-2-hydroxyethyl amides as potassium channel openers
10/05/2005EP1581499A1 Microsomal triglyceride transfer protein inhibitors
10/05/2005EP1581498A2 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581480A1 Cyclopentil-substituted glutaramide compounds as endopeptidasev inhibitors
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005EP1581474A1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
10/05/2005EP1581470A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1156039B1 Pyridazin-3-one derivatives and medicines containing the same
10/05/2005EP0775110B1 Arylthio compounds as antibacterial and antiviral agents
10/05/2005CN1678791A Method for delivering biologically active substances
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1678585A Therapeutic agents useful for treating pain
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1678311A Aryl carbonyl derivatives as therapeutic agents
10/05/2005CN1678192A Arthropodicidal anthranilamides
10/05/2005CN1676516A Novel method for industrialized preparation of trichloropyridine sodium alcoholate
10/05/2005CN1221536C New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/04/2005US6951945 Heteroaromatic glucokinase activators
10/04/2005US6951943 Integrin inhibitors
10/04/2005US6951886 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
10/04/2005US6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
10/04/2005US6951877 Materials and methods for treating hypercholesterolemia
10/04/2005US6951875 Conjugated aromatic compounds with a pyridine substituent
10/04/2005US6951872 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
10/04/2005US6951862 Calcium channel blockers comprising two benzhydril moieties
10/04/2005CA2238275C Metalloproteinase inhibitors
09/2005
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090291A1 Ion channel modulators
09/29/2005WO2005089269A2 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
09/29/2005WO2004072037A8 2,3'-bipyridines derivatives as selective cox-2 inhibitors
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215645 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction
09/29/2005US20050215600 Polymorphs of torsemide hydrochloride and process for production thereof
09/29/2005US20050215598 Phenylalanine derivatives
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050215588 Pyridyl cyanoguanidine compounds, e.g., 1-[2-(4-Piperidyl)-ethoxy-carbonyloxymethyl]-4-[N'-cyano-N''-(6-(4-chloro-phenoxy)-1-hexyl)-N-guanidino]-pyridinium chloride, hydrochloride; human and veterinary therapy of proliferative diseases such as cancers
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215563 Proteomimetic compounds and methods
09/29/2005US20050215542 Compounds for the treatment of diseases
09/29/2005US20050214249 Release nitric oxide under physiological conditions and are useful for treating biological disorders
09/29/2005US20050211954 Capable of controlling a tilt (or inclined) angle of aligned liquid crystal molecules
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2557746A1 Ion channel modulators
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1580188A1 Aryl ureas as kinase inhibitors
09/28/2005EP1578752A1 Method for producing pyridoxine or an acid addition salt thereof
09/28/2005EP1578747A2 Novel herbicides
09/28/2005EP1578735A1 Cyclopentyl glutaramides and their use as neutral endopeptidase inhibitors
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 633